1,314 results match your criteria: "FOCH Hospital[Affiliation]"
Eur J Surg Oncol
October 2024
Université Paris Cité, ENT - Head and Neck Surgery Department, AP-HP, Hôpital Lariboisière, INSERM U1141, F-75010, Paris, France.
Objectives: The management of the facial nerve (FN) is a major issue in parotid cancer, especially when there is no preoperative facial palsy and FN invasion is discovered intraoperatively. The aim of this study was to assess the impact of FN resection in patients with parotid cancer abutting the FN, without pretreatment facial palsy, using a propensity score matching.
Materials And Methods: Data from all patients treated between 2009 and 2020 for a primary parotid cancer abutting or invading the FN but without pretreatment facial palsy were extracted from the national multicentric REFCOR database.
J Otolaryngol Head Neck Surg
October 2024
Research Committee of the Young Otolaryngologists of the International Federation of Otorhinolaryngological Societies, Paris, France.
Objective: To review the current literature about surgical treatments of pediatric bilateral vocal fold paralysis (PBVFP).
Methods: A systematic review of the current literature in PubMed, Scopus, and Cochrane Library regarding etiologies and management of PBVFP was performed until November 2023 according to PRISMA statements. Quality assessment was assessed with Methodological Index for Non-Randomized Studies (MINORS) tool.
JAC Antimicrob Resist
October 2024
Infectious Disease Department, Raymond Poincaré Hospital, APHP, Garches, France.
Objectives: To describe the real-life use of temocillin for non-urinary tract infections, to assess its effectiveness in infections caused by ESBL-producing Enterobacterales, and to identify risk factors for treatment failure.
Method: Retrospective multicentric study in 14 tertiary care hospitals, including all patients who received at least one dose of temocillin for ESBL infections from 1 January 2016 to 31 December 2021 for non-urinary tract infections. Failure was a composite criterion defined within 28 day follow-up by persistence or reappearance of signs of infection, and/or switch to suppressive antibiotic treatment and/or death from infection.
JAMA Netw Open
October 2024
Division of Respirology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
J Am Soc Nephrol
October 2024
Université de Paris Cité, INSERM, PARCC, Paris Institute for Transplantation and Organ Regeneration, F-75015 Paris, France.
Eur Stroke J
October 2024
Department of Medicine, Division of Neurology, The Ottawa Hospital, Ottawa Hospital Research Institute and University of Ottawa, Ottawa, Canada.
Background: Patients with acute basilar artery occlusion (BAO) and low-to-moderate symptoms (National Institutes of Health Stroke Scale [NIHSS] < 10) are poorly represented in thrombectomy trials. Our objective is to compare thrombectomy and best medical management (BMT) in this population.
Methods: We compared data of all consecutive patients presenting with an initial NIHSS < 10 and acute symptomatic BAO included in two registries.
Anaesth Crit Care Pain Med
December 2024
Department of Anaesthesia and Pain Medicine, Foch Hospital, Suresnes, France; University of Versailles Saint Quentin, France.
Eur Arch Otorhinolaryngol
October 2024
Faculty of Medicine and Surgery, University of Enna Kore, Enna, 94100, Italy.
Fr J Urol
October 2024
Urology Department, Foch Hospital, Suresnes, France. Electronic address:
J Plast Reconstr Aesthet Surg
December 2024
Urology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France; Université Claude Bernard Lyon 1, Lyon, France. Electronic address:
BMC Med Ethics
October 2024
Famiréa Research Group, Medical Intensive Care Unit, APHP, Hospital Saint-Louis, Paris, France.
J Voice
October 2024
Haute Ecole Condorcet, Division of Speech Therapy, Saint-Ghislain, Belgium.
Objective: To evaluate the inter-rater reliability and internal consistency of the Reflux Sign Assessment-10 (RSA-10) among otolaryngologists and speech therapists with various experiences.
Methods: Six experts (2 otolaryngologists, 2 speech-therapists, and 2 speech-therapist students) rated 300 clinical images of oral, laryngeal, and pharyngeal signs from patients with laryngopharyngeal reflux disease diagnosis at the 24-hour hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring. Inter-rater reliability and internal consistency were evaluated with Intraclass Correlation (ICC) and Cronbach-α.
Clin Otolaryngol
January 2025
Department of Otolaryngoly-Head Neck Surgery, Foch Hospital, University of Paris Saclay, Paris, France.
Nat Commun
October 2024
Department of Genetics, Institut Curie, 75005, Paris, France.
Eur Arch Otorhinolaryngol
November 2024
Department of Surgery, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
Objective: To investigate the accuracy of information provided by ChatGPT-4o to patients about tracheotomy.
Methods: Twenty common questions of patients about tracheotomy were presented to ChatGPT-4o twice (7-day intervals). The accuracy, clarity, relevance, completeness, referencing, and usefulness of responses were assessed by a board-certified otolaryngologist and a board-certified intensive care unit practitioner with the Quality Analysis of Medical Artificial Intelligence (QAMAI) tool.
JAMA Netw Open
October 2024
Université Paris Cité, Inserm, U970, Paris Cardiovascular Research Center, Integrative Epidemiology of Cardiovascular Disease, Paris, France.
Importance: Most observational studies examining the association between hearing loss (HL) and cognitive impairment used subjective measures of hearing and addressed only one dimension of cognition, and very few investigated the potential benefit of hearing aids (HAs).
Objective: To evaluate objectively measured HL and several dimensions of cognition and estimate the association with HA use.
Design, Setting, And Participants: A cross-sectional analysis of the CONSTANCES cohort study, which recruited participants from January 1, 2012, to December 31, 2020, was conducted.
J Exp Med
November 2024
Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children, Paris, France.
Otolaryngol Head Neck Surg
September 2024
Department of Anatomy, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
Objective: To investigate the effectiveness of drug class changes in patients with refractory laryngopharyngeal reflux disease (LPRD).
Study Design: Retrospective case series with prospective data.
Setting: Multicenter study.
Oral Oncol
December 2024
Department of Surgery, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium; Department of Otolaryngology, Elsan Hospital, Poitiers, France; Department of Otolaryngology-Head Neck Surgery, Foch Hospital, UFR Simone Veil, University Versailles Saint-Quentin-en Yvelines (University Paris Saclay), Paris, France; Department of Otorhinolaryngology and Head and Neck Surgery, CHU Saint-Pierre, Brussels, Belgium. Electronic address:
Background: This systematic review investigated the surgical, functional, and oncological outcomes of transoral robotic supraglottic laryngectomy (TORS-SGL) for cT1-T3 laryngeal squamous cell carcinoma (LSCC).
Methods: Two investigators conducted an updated PubMed, Scopus, and Cochrane Library systematic review for studies investigating the surgical, functional, and oncological outcomes of TORS-SGL using the PRISMA statements. The bias analysis was conducted with the MINORS.
PLoS One
September 2024
URC-ECO, Hotel-Dieu Hospital, AP-HP, Paris, France.
An oral two-drug regimen (O2DR) in the form of a once-a-day single tablet is now recommended for treatment switching and treatment initiation for HIV. In clinical care, the process of treatment change refers to adaptation issues, both individual and within the care relationship. The study aim is to present the determinants involved in the acceptability of switching to O2DR in the PROBI (Patient-Reported Outcomes BItherapy) qualitative study.
View Article and Find Full Text PDFJ Stomatol Oral Maxillofac Surg
September 2024
Department of Stomatology, Oral & Maxillofacial Surgery, CHU Saint Pierre, Brussels, Belgium; Faculty of Medicine, Department of Human Anatomy and Experimental Oncology UMONS, Mons, Belgium.
Introduction: ChatGPT is an artificial intelligence based large language model with the ability to generate human-like response to text input, its performance has already been the subject of several studies in different fields. The aim of this study was to evaluate the performance of ChatGPT in the management of maxillofacial clinical cases.
Materials And Methods: A total of 38 clinical cases consulting at the Stomatology-Maxillofacial Surgery Department were prospectively recruited and presented to ChatGPT, which was interrogated for diagnosis, differential diagnosis, management and treatment.
Ear Nose Throat J
September 2024
Department of Physiology, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
Eur J Obstet Gynecol Reprod Biol
November 2024
Department of Anaesthesiology, Hôpital de la Croix-Rousse, Hospices civils de Lyon, Lyon, France; RESHAPE UMR 1290 INSERM, Université Lyon 1, Lyon, France.
Clin Oral Investig
September 2024
Dental School, University Brasil, Fernandópolis, Brazil.
Objective: To investigate the performance of ChatGPT in the differential diagnosis of oral and maxillofacial diseases.
Methods: Thirty-seven oral and maxillofacial lesions findings were presented to ChatGPT-3.5 and - 4, 18 dental surgeons trained in oral medicine/pathology (OMP), 23 general dental surgeons (DDS), and 16 dental students (DS) for differential diagnosis.
Int J Cancer
January 2025
Otolaryngology, Head and Neck Surgery Department, University Cancer Institute Toulouse and Toulouse University Hospital, Larrey Hospital, Toulouse, France.